Torrent Pharma Q3 Results: PAT jumps 52% to Rs 443 crore
Torrent Pharma Q3 Results: Torrent Pharmaceuticals reported a 52 per cent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023.
)
Torrent Pharma Q3 Results: Torrent Pharmaceuticals on Friday reported a 52 per cent increase in its consolidated profit after tax to Rs 443 crore for the third quarter ended December 2023. The drug firm had reported a net profit of Rs 292 crore in the October-December period of the last fiscal.
Its revenue increased by 10 per cent to Rs 2,732 crore in the third quarter compared to Rs 2,491 crore in the year-ago period, Torrent Pharmaceuticals said in a statement.
The company said its domestic business revenues increased 12 per cent year-on-year to Rs 1,415 crore in the October -December quarter this year.
Brazil's business grew by 26 per cent to Rs 312 crore, while the US business expanded by 6 per cent to Rs 274 crore in the third quarter.
German revenues for the October-December period witnessed a 12 per cent growth to Rs 270 crore in the December 2023 quarter.
Shares of the company on Friday ended 0.51 per cent up at Rs 2,524.70 apiece on the BSE.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
08:16 PM IST
Torrent Pharma slips over 3.25% after its Gujarat facility receives Form 483 with 5 observations from US FDA
Torrent Pharma shares jump 7% post strong Q4 results; should you buy, or sell pharma stock?
Torrent Pharma Q4 Results Preview: Drug maker likely to clock 56% jump in net profit, margin may expand by 300 bps
Torrent Pharmaceuticals falls 3% after in-line Q2 results; Brokerages mixed